Altered gene expression of adrenomedullin and its receptor system and molecular forms of tissue adrenomedullin in left ventricular hypertrophy induced by malignant hypertension

Regulatory Peptides

Volumn 112, Issue 1-3, 2003, Pages 71-78

  Tadokoro, Kazuyoshi ^a   Nishikimi, Toshio ^a   Mori, Yosuke ^a   Wang, Xin ^a   Akimoto, Kazumi ^a   Matsuoka, Hiroaki ^a  

^a DOKKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

Adrenomedullin; Hypertension; Left ventricular hypertrophy

Indexed keywords

ADRENOMEDULLIN; ADRENOMEDULLIN RECEPTOR; ATRIAL NATRIURETIC FACTOR; CALCITONIN RECEPTOR LIKE RECEPTOR; DEOXYCORTICOSTERONE ACETATE; MESSENGER RNA; RECEPTOR ACTIVITY MODIFYING PROTEIN 2; RECEPTOR ACTIVITY MODIFYING PROTEIN 3; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; ENZYME ACTIVITY; GENE EXPRESSION REGULATION; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE HYPERTROPHY; MALIGNANT HYPERTENSION; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; PROTEIN INDUCTION; RAT; TISSUE LEVEL;

EID: 0037445796     PISSN: 01670115     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-0115(03)00024-7     Document Type: Article

References (41)

1. Kitamura K., Kangawa K., Kawamoto M., Ichiki Y., Nakamura S., Matsuo H.et al. Adrenomedullin: a novel hypotensive peptide isolated from human pheochromocytoma. Biochem. Biophys. Res. Commun. 192:1993;553-560.
2. Sakata J., Shimokubo T., Kitamura K., Nishizono M., Ichiki Y., Kangawa K.et al. Distribution and characterization of immunoreactive rat adrenomedullin in tissue and plasma. FEBS Lett. 352:1994;105-108.
3. Owji A.A., Smith D.M., Coppoock H.A., Morgan D.G., Bhogal R., Ghatei M.A.et al. An abundant specific binding site for the novel vasodilator adrenomedullin in the rat. Endocrinology. 136:1995;2127-2134.
4. Horio T., Nishikimi T., Yoshihara F., Matsuo H., Takishita S., Kangawa K. Effects of adrenomedullin on cultured rat cardiac myocytes and fibroblasts. Eur. J. Pharmacol. 382:1999;1-9.
5. Tsuruda T., Kato J., Kitamura K., Kuwasako K., Imamura T., Koiwaya Y.et al. Adrenomedullin: a possible autocrine or paracrine inhibitor of hypertrophy of cardiomyocytes. Hypertension. 31:1998;505-510.
6. Tsuruda T., Kato J., Kitamura K., Kawamoto M., Kuwasako K., Imamura T.et al. An autocrine or a paracrine role of adrenomedullin in modulating cardiac fibroblast growth. Cardiovasc. Res. 43:1999;958-967.
7. Tomoda Y., Kikumoto K., Isumi Y., Katafuchi T., Tanaka A., Kangawa K.et al. Cardiac fibroblasts are major production and target cells of adrenomedullin in the heart in vitro. Cardiovasc. Res. 49:2001;721-730.
8. Shimokubo T., Sakata J., Kitamura K., Kangawa K., Matsuo H., Eto T. Adrenomedullin: changes in circulating and cardiac tissue concentration in Dahl salt-sensitive rats on a high-salt diet. Clin. Exp. Hypertens. 18:1996;949-961.
9. Morimoto A., Nishikimi T., Yoshihara F., Horio T., Nagaya N., Matsuo H.et al. Ventricular adrenomedullin levels correlate with the extent of cardiac hypertrophy in rats. Hypertension. 33:1999;1146-1152.
10. Sumimoto T., Nishikimi T., Mukai M., Matsuzaki K., Murakami E., Takishita S.et al. Plasma adrenomedullin concentrations and cardiac and arterial hypertrophy in hypertension. Hypertension. 30:1997;741-745.
11. Kennedy S.P., Sun D., Oleynek J.J., Hoth C.F., Kong J., Hill R.J. Expression of the rat adrenomedullin receptor or a putative human adrenomedullin receptor does not correlate with adrenomedullin binding or functional response. Biochem. Biophys. Res. Commun. 244:1998;832-837.
12. McLatchie L.M., Fraser N.J., Main M.J., Wise A., Brown J., Thompson N.et al. RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor. Nature. 393:1998;333-339.
13. Totsune K., Takahashi K., Mackenzie H.S., Murakami O., Arihara Z., Sone M.et al. Increased gene expression of adrenomedullin and adrenomedullin-receptor complexes, receptor-activity modifying protein (RAMP)2 and calcitonin-receptor-like receptor (CRLR) in the hearts of rats with congestive heart failure. Clin. Sci. 99:2000;541-546.
14. Oie E., Vinge L.E., Yndestad A., Sandberg C., Grogaard H.K., Attramadal H. Induction of a myocardial adrenomedullin signaling system during ischemic heart failure in rats. Circulation. 101:2000;415-422.
15. Kitamura K., Kato J., Kawamoto M., Tanaka M., Chino N., Kangawa K.et al. The intermediate form of glycine-extended adrenomedullin is the major circulating molecular form in human plasma. Biochem. Biophys. Res. Commun. 244:1998;551-555.
16. Nishikimi T., Matsuoka H., Shimada K., Matsuo H., Kangawa K. Production and clearance sites of two molecular forms of adrenomedullin in human plasma. Am. J. Hypertens. 13:2000;1032-1034.
17. Hirayama N., Kitamura K., Imamura T., Kato J., Koiwaya Y., Tsuji T.et al. Molecular forms of circulating adrenomedullin in patients with congestive heart failure. J. Endocrinol. 160:1999;297-303.
18. Sesoko S., Pegram B.L., Willis G.W., Frohlich E.D. DOCA-salt induced malignant hypertension in spontaneously hypertensive rats. J. Hypertens. 2:1984;49-54.
19. Nishikimi T., Yoshihara F., Kanazawa A., Okano I., Horio T., Nagaya N.et al. Role of increased circulating and renal adrenomedullin in rats with malignant hypertension. Am. J. Physiol. Regul. Integr. Comp. Physiol. 281:2001;R2079-R2087.
20. Yoshihara F., Nishikimi T., Horio T., Yutani C., Nagaya N., Matsuo H.et al. Ventricular adrenomedullin concentration is a sensitive biochemical marker for volume and pressure overload in rats. Am. J. Physiol. Heart Circ. Physiol. 278:2000;H633-H642.
21. Nagaya N., Nishikimi T., Yoshihara F., Horio T., Morimoto A., Kangawa K. Cardiac adrenomedullin gene expression and peptide accumulation after acute myocardial infarction in rats. Am. J. Physiol. Regul. Integr. Comp. Physiol. 278:2000;R1019-R1026.
22. Ohta H., Tsuji T., Asai S., Sasakura K., Teraoka H., Kitamura K.et al. One-step direct assay for mature-type adrenomedullin with monoclonal antibodies. Clin. Chem. 45:1999;244-251.
23. Ohta H., Tsuji T., Asai S., Tanizaki S., Sasakura K., Teraoka H.et al. A simple immunoradiometric assay for measuring the entire molecules of adrenomedullin in human plasma. Clin. Chim. Acta. 287:1999;131-143.
24. Miyata A., Kangawa K., Matsuo H. Molecular forms of atrial natriuretic peptides in rat tissues and plasma. J. Hypertens., Suppl. 4:1986;S9-S11.
25. Nishikimi T., Horio T., Sasaki T., Yoshihara F., Takishita S., Miyata A.et al. Cardiac production and secretion of adrenomedullin are increased in heart failure. Hypertension. 30:1997;1369-1375.
26. Nishikimi T., Miyata A., Horio T., Yoshihara F., Nagaya N., Takishita S.et al. Urocortin, a member of the corticotropin-releasing factor family, in normal and diseased heart. Am. J. Physiol. Heart Circ. Physiol. 279:2000;H3031-H3039.
27. Yanagita T., Yamamoto R., Sugano T., Kobayashi H., Uezono Y., Yokoo H.et al. Adrenomedullin inhibits spontaneous and bradykinin-induced but not oxytocin- or prostaglandin F(2alpha)-induced periodic contraction of rat uterus. Br. J. Pharmacol. 130:2000;1727-1730.
28. Qing X., Svaren J., Keith I.M. mRNA expression of novel CGRP1 receptors and their activity-modifying proteins in hypoxic rat lung. Am. J. Physiol., Lung Cell. Mol. Physiol. 280:2001;L547-L554.
29. Nishikimi T., Horio T., Kohmoto Y., Yoshihara F., Nagaya N., Inenaga T.et al. Molecular forms of plasma and urinary adrenomedullin in normal, essential hypertension and chronic renal failure. J. Hypertens. 19:2001;765-773.
30. Asakawa H., Nishikimi T., Suzuki T., Hara S., Tsubokou Y., Yagi H.et al. Elevation of two molecular forms of adrenomedullin in plasma and urine in patients with acute myocardial infarction treated with early coronary angioplasty. Clin. Sci. 100:2001;117-126.
31. Nishikimi T., Nagata S., Sasaki T., Yoshihara F., Nagaya N., Horio T.et al. The active molecular form of plasma adrenomedullin is extracted in the pulmonary circulation in patients with mitral stenosis: possible role of adrenomedullin in pulmonary hypertension. Clin. Sci. 100:2001;61-66.
32. Maltese J.Y., Oyarce A.M., Eipper B.A. Prevalence and turnover of peptidylglycine alpha-amidating monooxygenase mRNA in atrial cardiomyocytes. J. Mol. Cell. Cardiol. 28:1996;155-163.
33. Shimokubo T., Sakata J., Kitamura K., Kangawa K., Matsuo H., Eto T. Alterations in tissue concentration and gene expression of adrenomedullin in spontaneously hypertensive rats. Pathophysiology. 3:1995;223-226.
34. Shimokubo T., Sakata J., Kitamura K., Kangawa K., Matsuo H., Eto T. Adrenomedullin: changes in circulating and cardiac tissue concentration in Dahl salt-sensitive rats on a high-salt diet. Clin. Exp. Hypertens. 18:1996;949-961.
35. Fraser N.J., Wise A., Brown J., McLatchie L.M., Main M.J., Foord S.M. The amino terminus of receptor activity modifying proteins is a critical determinant of glycosylation state and ligand binding of calcitonin receptor-like receptor. Mol. Pharmacol. 55:1999;1054-1059.
36. Yoshihara F., Nishikimi T., Okano I., Horio T., Yutani C., Matsuo H.et al. Alterations of intrarenal adrenomedullin and its receptor system in heart failure rats. Hypertension. 37:2001;216-222.
37. Fukuhara M., Tsuchihashi T., Abe I., Fujishima M. Cardiovascular and neurohormonal effects of intravenous adrenomedullin in conscious rabbits. Am. J. Physiol. 269:1995;R1289-R1293.
38. Szokodi I., Kinnunen P., Tavi P., Weckstrom M., Toth M., Ruskoaho H. Evidence for cAMP-independent mechanisms mediating the effects of adrenomedullin, a new inotropic peptide. Circulation. 97:1998;1062-1070.
39. Shimosawa T., Shibagaki Y., Ishibashi K., Kitamura K., Kangawa K., Kato S.et al. Adrenomedullin, an endogenous peptide, counteracts cardiovascular damage. Circulation. 105:2002;106-111.
40. Horio T., Nishikimi T., Yoshihara F., Matsuo H., Takishita S., Kangawa K. Inhibitory regulation of hypertrophy by endogenous atrial natriuretic peptide in cultured cardiac myocytes. Hypertension. 35:2000;19-24.
41. Oliver P.M., Fox J.E., Kim R., Rockman H.A., Kim H.S., Reddick R.L.et al. Hypertension, cardiac hypertrophy, and sudden death in mice lacking natriuretic peptide receptor A. Proc. Natl. Acad. Sci. U. S. A. 94:1997;14730-14735.